BOSTON - Elliot L. Chaikof, MD, PhD, the chief of vascular surgery at Emory University in Atlanta and a leader in the development of minimally invasive endovascular therapies for aortic aneurysms, carotid disease and peripheral vascular disease, has been named chair of the
Roberta and Stephen R. Weiner Department of Surgery and surgeon-in-chief at Beth Israel Deaconess Medical Center (BIDMC).
Chaikof will join the medical center on Aug. 1. He succeeds James Hurst, MD, who has been acting chief of the department since December 2007.
"Elliot Chaikof is a gifted surgeon and scientist who brings great leadership skills to BIDMC's already renowned surgery department," said Paul Levy, BIDMC's President and CEO. "He has a track record of bringing together the engineering and medical communities, enabling the development of clinically beneficial, cost-effective therapies that use evidence-based guidelines and practice standards in his field. That philosophy and expertise are critical in today's health care environment.
"On behalf of the board and the entire medical center, I also extend our enormous thanks to Jim Hurst, MD for his leadership of the surgery department over the past few years."
"I am proud to assume a leadership role in a hospital that has long been at the forefront of high-quality surgical care and research," said Chaikof. "When I look at the history of contributions made by members of this department, past and current, and the legacy of compassionate care at BIDMC, I feel very honored to become part of it."
"Among the important qualities Dr. Chaikof brings to BIDMC is that he is an outstanding teacher and mentor," said Stuart Rosenberg, MD, President & CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center. "He has helped develop the careers of residents, graduate students, postdoctoral fellows, and junior faculty engaged in efforts to provide surgical care of the highest quality as well to excel in research, innovation and discovery."
Born and raised in Toronto, Chaikof earned BA and MD degrees at the Johns Hopkins University in Baltimore. He completed a residency in general surgery at the Massachusetts General Hospital and while a surgical resident, received a PhD in chemical engineering at the Massachusetts Institute of Technology with a focus on artificial organs and the design of biomaterials for reconstructive surgery.
Following his surgical training in Boston, he completed additional training in vascular surgery at the Emory University School of Medicine where he joined the surgical faculty, most recently holding the John E. Skandalakis Chair of Surgery at Emory University as well as chief of vascular surgery and director of the residency in vascular surgery.
He has been regularly listed by Atlanta Magazine as among Atlanta's Top Doctors and in the Castle Connolly Guide of Best Doctors in America, and has been President of the Atlanta Vascular Society.
Chaikof has been active in the development of minimally invasive endovascular therapies for treatment of aortic aneurysms, carotid disease, and peripheral arterial disease, as well as novel biologics and tissue engineered products for the cure of venous and arterial disease.
Chaikof holds secondary appointments as an adjunct professor in the School of Chemical and Biomolecular Engineering at the Georgia Institute of Technology and is a member of the faculty in the Department of Biomedical Engineering. He has been elected to the American Surgical Association, the College of Fellows of the Society of Vascular Surgery, the American Society for Clinical Investigation, and the American Institute of Medical and Biomedical Engineering. He has been honored with named lectureships at the University of Michigan, the University of California-San Francisco, and Harvard Medical School and is President-elect of the International Society of Applied Cardiovascular Biology.
Chaikof has promoted alliances of clinicians, engineers, and biologists and in the process developed molecularly engineered materials that have enabled advances in cell-based therapies, artificial organs and engineered living tissues, which define the evolving field of regenerative medicine. His laboratory has received over $20 million in federal funding for basic science investigations from the NIH and NSF, and funding from the American Heart Association and the Juvenile Diabetes Research Foundation.
He has published over 220 publications in major surgical journals, the
New England Journal of Medicine,
Nature, as well as in leading journals in the fields of engineering and chemistry. Nearly two-dozen patents have been issued or filed based on work in his laboratory.
His leadership of a major clinical unit and large projects that span and bring together schools of Medicine and Engineering and constituency organizations at Emory has contributed to public policy designed to improve the quality of care of the surgical patient.
Chaikof has three children and is married to Melissa Kershman Chaikof, a research analyst, who received her BA from the University of Pennsylvania and MS in applied mathematics from Johns Hopkins. She worked at the MITRE Corporation when they resided in Boston. She currently serves on the Board of the Coalition of Usher Syndrome Research and has been previously active in Auditory-Verbal International, which is now part of the Alexander Graham Bell Association for the Deaf and Hard of Hearing.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and consistently ranks among the top four
in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit